FlyPharma Copenhagen 2026

Case Study: The Radioligand Journey

   


This session highlights how medical innovation in radiopharma and personalized medicine is outpacing current logistics infrastructure. It explores the specialized challenges of shipping radioactive agents, focusing on ultra-short lead times, safety compliance, and the friction caused by inconsistent European regulations. The discussion emphasizes the urgent need for a bespoke supply chain to support these time-sensitive therapies.

 

Speakers